Medulloblastoma — Trials

Medulloblastoma — Trials · CancerIndex

Clinical trials

Registered studies

204 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 61
Recruiting: 29
Ph III recruiting: 2
Growth YoY: —
Industry share: 5%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (28)

clinicaltrialsPublishedShowing 1–30 of 30 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00407433	Clinical Studies of Gemcitabine-Oxaliplatin	completed	Phase 2	156	Gustave Roussy, Cancer Campus, Grand ParisOTHER	1	Aug 17, 2026	clinicaltrials
NCT01326104	Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor(Re-MATCH)	completed	Phase 2	26	University of FloridaOTHER	1	Aug 13, 2026	clinicaltrials